60 related articles for article (PubMed ID: 10872659)
1. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma.
Albarracin CT; Jafri J; Montag AG; Hart J; Kuan SF
Hum Pathol; 2000 Jun; 31(6):672-7. PubMed ID: 10872659
[TBL] [Abstract][Full Text] [Related]
2. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.
Semino-Mora C; Liu H; McAvoy T; Nieroda C; Studeman K; Sardi A; Dubois A
Ann Surg Oncol; 2008 May; 15(5):1414-23. PubMed ID: 18299935
[TBL] [Abstract][Full Text] [Related]
3. Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression.
Hirabayashi K; Yasuda M; Kajiwara H; Itoh J; Miyazawa M; Hirasawa T; Muramatsu T; Murakami M; Mikami M; Osamura RY
Acta Histochem Cytochem; 2008 Apr; 41(2):15-21. PubMed ID: 18493590
[TBL] [Abstract][Full Text] [Related]
4. Assessment of MUC5AC and MUC2 Immunoexpression in Glandular Odontogenic Cysts, Dentigerous Cysts, and Mucoepidermoid Carcinomas.
Jot K; Nayyar V; Surya V; Kakkar A; Satapathy S; Roychoudhury A; Mishra D
Appl Immunohistochem Mol Morphol; 2024 Apr; 32(4):183-188. PubMed ID: 38478391
[TBL] [Abstract][Full Text] [Related]
5. Mucin-producing tumors of the ovary--preoperative differentiation between metastatic ovarian mucinous carcinoma and primary mucinous malignant tumors.
Cai SQ; Wu MR; Ma XL; Lu JJ; Qiang JW; Guan YY; Zeng MS; Zhou JJ
J Ovarian Res; 2024 Mar; 17(1):59. PubMed ID: 38481236
[TBL] [Abstract][Full Text] [Related]
6. POFUT1 and PLAGL2 are characteristic markers of mucinous colorectal cancer associated with MUC2 expression.
Monno M; Ogiri M; Seishima R; Suzuki Y; Hattori K; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
Cell Biochem Funct; 2024 Mar; 42(2):e3989. PubMed ID: 38500386
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma.
Manne A; Yu L; Hart PA; Tsung A; Esnakula A
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835525
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma.
Seko A; Nagata K; Yonezawa S; Yamashita K
Jpn J Cancer Res; 2002 May; 93(5):507-15. PubMed ID: 12036446
[TBL] [Abstract][Full Text] [Related]
9. A rare case of primary bladder carcinoma discovered by ovarian metastasis.
Qin Z; Wang Y; Zheng A
Asian J Surg; 2023 Nov; 46(11):4903-4904. PubMed ID: 37328369
[No Abstract] [Full Text] [Related]
10. Comprehensive imaging diagnosis of ovarian metastatic tumors: A bibliometric analysis.
Tan HY
Asian J Surg; 2024 Jun; ():. PubMed ID: 38834473
[No Abstract] [Full Text] [Related]
11. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
Han L; Pansare V; Al-Abbadi M; Husain M; Feng J
Diagn Cytopathol; 2010 May; 38(5):333-6. PubMed ID: 19856421
[TBL] [Abstract][Full Text] [Related]
12. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 2003 Aug; 27(8):1031-51. PubMed ID: 12883236
[TBL] [Abstract][Full Text] [Related]
14. Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment.
Wang Y; Liu L; Yu Y
Heliyon; 2023 Aug; 9(8):e19221. PubMed ID: 37664708
[TBL] [Abstract][Full Text] [Related]
15. Measuring the multifaceted roles of mucin-domain glycoproteins in cancer.
Riley NM; Wen RM; Bertozzi CR; Brooks JD; Pitteri SJ
Adv Cancer Res; 2023; 157():83-121. PubMed ID: 36725114
[TBL] [Abstract][Full Text] [Related]
16. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples.
Rico SD; Mahnken M; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Möller-Koop C; Fraune C; Möller K; Menz A; Bernreuther C; Jacobsen F; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Marx AH
Technol Cancer Res Treat; 2021; 20():15330338211043328. PubMed ID: 34547930
[No Abstract] [Full Text] [Related]
17. Analysis of blood group antigens on MUC5AC in mucinous ovarian cancer tissues using in situ proximity ligation assay.
Mateoiu C; Vitiazeva V; Kristjansdottir B; Weijdegård B; Örnros J; Gallini R; Kamali-Moghaddam M; Sundfeldt K; Karlsson NG
Glycobiology; 2021 Dec; 31(11):1464-1471. PubMed ID: 34459484
[TBL] [Abstract][Full Text] [Related]
18. Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.
Rico SD; Höflmayer D; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Möller-Koop C; Perez D; Izbicki JR; Neipp M; Mofid H; Lárusson H; Daniels T; Isbert C; Coerper S; Ditterich D; Rupprecht H; Goetz A; Fraune C; Möller K; Menz A; Bernreuther C; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Lebok P; Burandt E; Krech T; Marx AH
Med Mol Morphol; 2021 Jun; 54(2):156-165. PubMed ID: 33373033
[TBL] [Abstract][Full Text] [Related]
19. A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix.
Li H; Jing X; Yu J; Liu J; Zhang T; Chen S; Zhang X
Diagn Pathol; 2020 Aug; 15(1):104. PubMed ID: 32843061
[TBL] [Abstract][Full Text] [Related]
20. Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease.
Sauriol A; Simeone K; Portelance L; Meunier L; Leclerc-Desaulniers K; de Ladurantaye M; Chergui M; Kendall-Dupont J; Rahimi K; Carmona E; Provencher DM; Mes-Masson AM
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
